Говард Джейкобсон - Полезная еда. Развенчание мифов о здоровом питании

Light D. W., Warburton R. N. Extraordinary Claims Require Extraordinary Evidence // Journal of Health Economics, 2005. Vol. 24. P. 1030–1033.

Light D. W., Warburton R. N. Drug R&D Costs Questioned: Widely Quoted Average Cost to Bring Drugs to Market Doesn’t Appear to Hold Up to Scrutiny // Genetic Engineering & Biotechnology News, 2011, July 1. Vol. 31, N. 13 // http://www.genengnews.com/gen-articles/drug-r-d-costs-questioned/3707/.

Direct-to-Consumer Advertising // Wikipedia, последнее обновление от 16 апреля 2012 года // http://en.wikipedia.org/wiki/Direct-to-consumer_advertising.

Big Pharma Spends More on Advertising Than Research and Development, Study Finds // ScienceDaily (blog), January 7, 2008 // http://www.sciencedaily.com/releases/2008/01/080105140107.htm.

The Mount Sinai Hospital/Mount Sinai School of Medicine. Majority of Pharmaceutical Ads Do Not Adhere to FDA Guidelines, New Study Finds // ScienceDaily, August 18, 2011 // http://www.sciencedaily.com/releases/2011/08/110818093052.htm.

York University. Big Pharma Spends More on Advertising than Research and Development, Study Finds // ScienceDaily, January 7, 2008 // http://www.sciencedaily.com/releases/2008/01/080105140107.htm.

Pharmaceutical Industry // Wikipedia, последнее обновление от 30 октября 2012 года // http://en.wikipedia.org/wiki/Pharmaceutical_Industry.

Wikipedia. List by countries by GDP (nominal), по состоянию на 2 декабря 2012 года // http://en.wikipedia.org/wiki/List_of_countries_by_GDP_(nominal).

Yusuf S. Two Decades of Progress in Preventing Vascular Disease // Lancet, 2002. Vol. 360, N. 9326. P. 2–3; Wald N. J., Law M. R. A Strategy to Reduce Cardiovascular Disease by More Than 80 % // BMJ, 2003. Vol. 326, N. 7404. P. 1419–1424; Lonn E., Bosch J., Teo K. K. et al. The Polypill in the Prevention of Cardiovascular Diseases: Key Concepts, Current Status, Challenges, and Future Directions // Circulation, 2010. Vol. 122, N. 20. P. 2078–2088.

Wald and Law. A Strategy to Reduce.

Lonn et al. The Polypill.

Wald and Law. A Strategy to Reduce.

Combination Pharmacology and Public Health Research Working Group. Combination Pharmacotherapy for Cardiovascular Disease // Annals of Internal Medicine, 2005. Vol. 143, N. 8. P. 593–599; Wise J. Polypill Holds Promise for People with Chronic Disease // Bulletin of the World Health Organization, 2005. Vol. 83, N. 12. P. 885–887.

Lonn et al. The Polypill.

Ebrahim S., Beswick A., Burke M., Davey S. G. Multiple Risk Factor Interventions for Primary Prevention of Coronary Heart Disease // Cochrane Database of Systemic Reviews, October 18, 2006: CD001561.

Ebrahim et al. Multiple risk factor interventions.

Frequently Asked Questions August 2010: CODEX and Dietary Supplements // CodexFund.com, по состоянию на 11 ноября 2012 года // http://www.codexfund.com/faq.htm.

Committee on Diet, Nutrition, and Cancer, Diet, Nutrition, and Cancer. Washington, DC: National Academies Press, 1982.

Thurston. Dietary Supplements.

Thurston. Dietary Supplements. Оценки размеров индустрии пищевых добавок варьируют в зависимости от того, какие продукты учитываются. Нутриенты – только часть этого рынка.

Однако в последние годы профессоров, желающих проводить исследования, все чаще принуждают искать финансирование, чтобы покрыть расходы на их зарплату.

Martinson B. C., Anderson M. S., de Vries R. Scientists Behaving Badly // Nature, 2005, June 9. Vol. 435. P. 737–738.

Исследования нашей лаборатории практически полностью финансировал Национальный институт рака НИЗ и в небольшом объеме – Американский институт исследований рака, Американское онкологическое общество и другие общественные организации.

Farbstein et al. Antioxidant Vitamins.

Bjelakovic et al. Mortality in Randomized Trials; Miller et al. Meta-analysis; Lonn et al. Effects of Long-Term Vitamin E.

Augustyniak et al. Natural and Synthetic Antioxidants; Farbstein et al. Antioxidant Vitamins; Aggarwal et al., Tocotrienols.

Smith R. Medical Journals: A Gaggle of Golden Geese // BMJ Group (blog), July 3, 2012 // http://blogs.bmj.com/bmj/2012/07/03/richard-smith-medical-journals-a-gaggle-of-golden-geese/.

Lundh A., Barbateskovic M., Hrobjartsson A., Gotzsche P. C. Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study // PLoS Medicine, 2010. Vol. 7. P. 1–7.

Handel A. E., Patel S. V., Pakpoor J. et al. High Reprint Orders in Medical Journals and Pharmaceutical Industry Funding: Case-control Study // British Medical Journal, 2012, June 28. Vol. 344. P. e4214, doi:10.1136/bmj.e4212.

Goldstein J. Whole Foods CEO: «We sell a bunch of junk» // Wall Street Journal Health Blog, August 6, 2009 // http://blogs.wsj.com/health/2009/08/05/whole-foods-ceo-we-sell-a-bunch-of-junk/.

Goldhamer A., Lisle D. L., Parpia B. et al. Medically Supervised Water-Only Fasting in the Treatment of Hypertension // Journal of Manipulative and Physiological Therapeutics, 2001. Vol. 24, N. 5. P. 335–339; Goldhamer A., Lisle D. L., Parpia B. et al. Medically Supervised Water-Only Fasting in the Treatment of Borderline Hypertension // Journal of Alternative and Complementary Medicine, 2002, October. Vol. 8, N. 5. P. 643–650.

Gardner C. D., Kiazand A., Alhassan S. et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for Change in Weight and Related Risk Factors among Overweight Premenopausal Women. The A to Z Weight Loss Study: A Randomized Trial // Journal of the American Medical Association, 2007. Vol. 297, N. 9. P. 969–977.

Grants / The Dr. Robert C. and Veronica Atkins Foundation. По состоянию на 1 ноября 2012 года // http://www.atkinsfoundation.org/grants.asp.

Lehrer J. The News Hour with Jim Lehrer. January 20, 2007.

Emery C., Rockoff J. Cancer Death Rate Falls // News & Observer (Raleigh, NC), January 18, 2007, 1A, 14A.

Associated Press. Cancer Deaths Drop for 2nd Straight Year // MSNBC.com, January 17, 2007 // http://www.msnbc.msn.com/id/16668688/ns/health-cancer/t/cancer-deaths-decline-nd-straight-year/.